These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 24073843

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic renal disease progression: treatment strategies and potassium intake.
    Sinha AD, Agarwal R.
    Semin Nephrol; 2013 May; 33(3):290-9. PubMed ID: 23953806
    [Abstract] [Full Text] [Related]

  • 3. A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients.
    Kaisar MO, Wiggins KJ, Sturtevant JM, Hawley CM, Campbell SB, Isbel NM, Mudge DW, Bofinger A, Petrie JJ, Johnson DW.
    Am J Kidney Dis; 2006 May; 47(5):809-14. PubMed ID: 16632019
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of use of dates on serum potassium in nondiabetic hemodialysis patients.
    Siddiqi N, El Shahat O, Bokhari E, Roujouleh H, Hamid MH, Sheikh I, El-Sayed H, Saleh A, Seddik A.
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1018-22. PubMed ID: 19861864
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Karaboyas A, Zee J, Brunelli SM, Usvyat LA, Weiner DE, Maddux FW, Nissenson AR, Jadoul M, Locatelli F, Winkelmayer WC, Port FK, Robinson BM, Tentori F.
    Am J Kidney Dis; 2017 Feb; 69(2):266-277. PubMed ID: 27866964
    [Abstract] [Full Text] [Related]

  • 8. We Use Dialysate Potassium Levels That Are Too Low in Hemodialysis.
    Tucker B, Moledina DG.
    Semin Dial; 2016 Jul; 29(4):300-2. PubMed ID: 27061895
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term low-dose spironolactone therapy is safe in oligoanuric hemodialysis patients.
    Matsumoto Y, Kageyama S, Yakushigawa T, Arihara K, Sugiyama T, Mori Y, Sugiyama H, Ohmura H, Shio N.
    Cardiology; 2009 Jul; 114(1):32-8. PubMed ID: 19342857
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A new treatment forInterdialytic hyperkalemia - the use of fosinopril sodium.
    Mousa D, Rassoul Z, Popovich W, Hassan A, Margate V, Hawas F, Suleiman M, Al Khader A.
    Am J Nephrol; 1999 Jul; 19(3):395-9. PubMed ID: 10393377
    [Abstract] [Full Text] [Related]

  • 18. [The ECG changes during the performance of hemodialysis using dialysis solution concentrates with different potassium levels in patients with chronic kidney failure and normokalemia].
    Alavi AA, Riabykina GV, Zaruba AIu, Kutsenko AI, Kukharchuk VV, Eliseev AO.
    Ter Arkh; 1993 Jul; 65(4):58-60. PubMed ID: 8059409
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW, Won YW, Yi JH, Kim HJ.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.